Today

Agents

Chat

Arena

Discover

More

App

Immuneering CFO Andrew Gengos files initial beneficial ownership statement - IMRX News | Rallies

Immuneering CFO Andrew Gengos files initial beneficial ownership statement

IMRX•2026-07-16

Form 3 filing by Immuneering CFO

Immuneering CFO Andrew Gengos filed an initial Form 3 showing direct ownership of 225,000 shares of Class A common stock as of July 16, 2026.*

Related News

Vaxcyte files Form 3 initial beneficial ownership statement for director John Markels

PCVX•2026-07-16

Radian Group General Counsel Edward J. Hoffman sells 20,000 shares for $780,000

RDN•2026-07-16

Unity Software director Shlomo Dovrat resigns, effective July 24

Sources

S

Immuneering CFO Andrew Gengos files initial beneficial ownership statement

Sec

D

Datavault AI names Arqit co-founder Barry Childe as chief information security officer

DVLT•2026-07-16

BioRestorative CEO Lance Alstodt, CFO Robert Kristal resign effective immediately

BRTX•2026-07-16